Dr. Seema A. Khan, M.D.
Claim this profileNorthwestern University
Area of expertise
Breast Cancer
Seema A. Khan, M.D. has run 7 trials for Breast Cancer. Some of their research focus areas include:
Ductal Carcinoma In Situ
Seema A. Khan, M.D. has run 7 trials for Ductal Carcinoma In Situ. Some of their research focus areas include:
Affiliated Hospitals
Northwestern University
Clinical Trials Seema A. Khan, M.D. is currently running
Tamoxifen
for Breast Cancer Risk Reduction
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well established risk factor for breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works by blocking the effects of the hormone estrogen in the breast. Tamoxifen has been shown to reduce breast density, even at reduced dosages, and is approved for the prevention of breast cancer.
Recruiting
1 award
Phase 2
7-Gene Biosignature
for Ductal Carcinoma
This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions. Patients meeting the eligibility criteria (see below) will be eligible for participation and the investigators will obtain written informed consent. A central Institutional Review Board (IRB), WCG IRB, will approve the protocol and each participating institution.
Recruiting
1 award
N/A
7 criteria
More about Seema A. Khan, M.D.
Clinical Trial Related
7 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Seema A. Khan, M.D. has experience with
- Tamoxifen
- Afimoxifene
- Endoxifen Hydrochloride
- DCISionRT Test
- Placebo
- Conjugated Estrogens/Bazedoxifene
Breakdown of trials Seema A. Khan, M.D. has run
Breast Cancer
Ductal Carcinoma In Situ
Lobular Carcinoma in Situ
DCIS
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Seema A. Khan, M.D. specialize in?
Seema A. Khan, M.D. focuses on Breast Cancer and Ductal Carcinoma In Situ. In particular, much of their work with Breast Cancer has involved BRCA1 positive patients, or patients who are Stage II.
Is Seema A. Khan, M.D. currently recruiting for clinical trials?
Yes, Seema A. Khan, M.D. is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Seema A. Khan, M.D. has studied deeply?
Yes, Seema A. Khan, M.D. has studied treatments such as Tamoxifen, Afimoxifene, Endoxifen Hydrochloride.
What is the best way to schedule an appointment with Seema A. Khan, M.D.?
Apply for one of the trials that Seema A. Khan, M.D. is conducting.
What is the office address of Seema A. Khan, M.D.?
The office of Seema A. Khan, M.D. is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.